ELEM Biotech starts business

BSC’s spinoff company ELEM Biotech is born to commercialize on a Cloud-Deployed Software-as-a-Service basis the use of the HPC-based simulation code Alya for biomedical research. ELEM will become a Virtual Humans Factory, where in-silico trials can be performed thanks to a specifically designed user interface. Although ELEM’s first target will be the cardiovascular and respiratory domains, our vision is to progressively move to all organs and systems. Alya has a strong record on the efficient use of massively parallel computational resources, all this power will be put directly on the hands of clinicians, biologists and engineers from different realms: clinics, medical devices, pharma and CROs.